Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders: a Pilot Study

Trial Profile

Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders: a Pilot Study

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 25 Feb 2016

At a glance

  • Drugs Denosumab (Primary)
  • Indications Dermatomyositis; Juvenile rheumatoid arthritis; Polyarthritis; Psoriatic arthritis; Systemic vasculitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Feb 2016 Planned initiation date changed from 1 Jun 2015 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
    • 23 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top